133 related articles for article (PubMed ID: 28378638)
1. Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.
de Sousa JF; Torrieri R; Serafim RB; Di Cristofaro LF; Escanfella FD; Ribeiro R; Zanette DL; Paçó-Larson ML; da Silva WA; Tirapelli DP; Neder L; Carlotti CG; Valente V
Tumour Biol; 2017 Apr; 39(4):1010428317694552. PubMed ID: 28378638
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of
Tran OT; Tadesse S; Chu C; Kidane D
Tumour Biol; 2020 May; 42(5):1010428320918404. PubMed ID: 32364878
[TBL] [Abstract][Full Text] [Related]
3. EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients.
Dai Y; Tang Z; Yang Z; Zhang L; Deng Q; Zhang X; Yu Y; Liu X; Zhu J
Cell Cycle; 2018; 17(19-20):2386-2397. PubMed ID: 30328366
[TBL] [Abstract][Full Text] [Related]
4. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
5. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
6. Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.
Jiang Z; Hu J; Li X; Jiang Y; Zhou W; Lu D
Neurosci Lett; 2006 Dec; 409(2):112-7. PubMed ID: 17034947
[TBL] [Abstract][Full Text] [Related]
7. [IDH1 mutation and MGMT expression in astrocytoma and the relationship with prognosis after radiotherapy].
Jiang M; Dong X; Li J; Li J; Qi J
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):668-72. PubMed ID: 25567592
[TBL] [Abstract][Full Text] [Related]
8. The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas.
Hara A; Hashimura M; Tsutsumi K; Akiya M; Inukai M; Ohta Y; Saegusa M
Cancer Med; 2016 Dec; 5(12):3412-3425. PubMed ID: 27790861
[TBL] [Abstract][Full Text] [Related]
9. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
[TBL] [Abstract][Full Text] [Related]
10. IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK.
Becher OJ; Peterson KM; Khatua S; Santi MR; MacDonald TJ
J Child Neurol; 2008 Oct; 23(10):1205-13. PubMed ID: 18952587
[TBL] [Abstract][Full Text] [Related]
11. EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomas.
Mittelbronn M; Harter P; Warth A; Lupescu A; Schilbach K; Vollmann H; Capper D; Goeppert B; Frei K; Bertalanffy H; Weller M; Meyermann R; Lang F; Simon P
Brain Pathol; 2009 Apr; 19(2):195-204. PubMed ID: 18489490
[TBL] [Abstract][Full Text] [Related]
12. Human Exonuclease 1 (EXO1) Regulatory Functions in DNA Replication with Putative Roles in Cancer.
Keijzers G; Bakula D; Petr MA; Madsen NGK; Teklu A; Mkrtchyan G; Osborne B; Scheibye-Knudsen M
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30585186
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
14. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
15. Total copy number variation as a prognostic factor in adult astrocytoma subtypes.
Mirchia K; Sathe AA; Walker JM; Fudym Y; Galbraith K; Viapiano MS; Corona RJ; Snuderl M; Xing C; Hatanpaa KJ; Richardson TE
Acta Neuropathol Commun; 2019 Jun; 7(1):92. PubMed ID: 31177992
[TBL] [Abstract][Full Text] [Related]
16. Gene expression microarray analysis reveals prognostic markers of survival in high grade astrocytomas.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Neurol Res; 2018 Sep; 40(9):744-751. PubMed ID: 29781781
[TBL] [Abstract][Full Text] [Related]
17. Relationship between CacyBP/SIP expression and prognosis in astrocytoma.
Zhao W; Wang C; Wang J; Ge A; Li Y; Li W; Lu Y
J Clin Neurosci; 2011 Sep; 18(9):1240-4. PubMed ID: 21764585
[TBL] [Abstract][Full Text] [Related]
18. Modulation of HJURP (Holliday Junction-Recognizing Protein) levels is correlated with glioblastoma cells survival.
Valente V; Serafim RB; de Oliveira LC; Adorni FS; Torrieri R; Tirapelli DP; Espreafico EM; Oba-Shinjo SM; Marie SK; Paçó-Larson ML; Carlotti CG
PLoS One; 2013; 8(4):e62200. PubMed ID: 23638004
[TBL] [Abstract][Full Text] [Related]
19. IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.
Thon N; Eigenbrod S; Kreth S; Lutz J; Tonn JC; Kretzschmar H; Peraud A; Kreth FW
Cancer; 2012 Jan; 118(2):452-60. PubMed ID: 21717448
[TBL] [Abstract][Full Text] [Related]
20. Sumoylation regulates EXO1 stability and processing of DNA damage.
Bologna S; Altmannova V; Valtorta E; Koenig C; Liberali P; Gentili C; Anrather D; Ammerer G; Pelkmans L; Krejci L; Ferrari S
Cell Cycle; 2015 Aug; 14(15):2439-50. PubMed ID: 26083678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
